APA (7th ed.) Citation

Brodtkorb, T., Bell, M., Irving, A., Laramée, P., & Irving, A. H. (2016). The Cost Effectiveness of Nalmefene for Reduction of Alcohol Consumption in Alcohol-Dependent Patients with High or Very High Drinking-Risk Levels from a UK Societal Perspective. CNS Drugs, 30(2), 163. https://doi.org/10.1007/s40263-016-0310-2

Chicago Style (17th ed.) Citation

Brodtkorb, Thor-Henrik, Melissa Bell, Adam Irving, Philippe Laramée, and Adam H. Irving. "The Cost Effectiveness of Nalmefene for Reduction of Alcohol Consumption in Alcohol-Dependent Patients with High or Very High Drinking-Risk Levels from a UK Societal Perspective." CNS Drugs 30, no. 2 (2016): 163. https://doi.org/10.1007/s40263-016-0310-2.

MLA (9th ed.) Citation

Brodtkorb, Thor-Henrik, et al. "The Cost Effectiveness of Nalmefene for Reduction of Alcohol Consumption in Alcohol-Dependent Patients with High or Very High Drinking-Risk Levels from a UK Societal Perspective." CNS Drugs, vol. 30, no. 2, 2016, p. 163, https://doi.org/10.1007/s40263-016-0310-2.